Cardiac- Vasodilators Flashcards
Nitroglycerin MOA
Forms free radical nitric oxide in turn causing smooth muscle relaxation. Venous>arteriole. Primarily reduces cardiac oxygen demand by decreasing preload (left ventricular end- diastolic pressure); may modestly reduce afterload; dilates coronary arteries and improves collateral flow to ischemic regions
Nitroglycerin contraindications, cautions and adverse effects
Hypersensitivity, concurrent use of PDE-5 inhibitors (viagra, levitra, cialis), acute circulatory failure/shock, increased ICP, severe anemia
Avoid in SBP <90 or >30 below baseline,
30>HR>100, and/or suspected RVI
Adverse reactions:
Headache, hypotension
*tachyphylaxis develops within 24-48hrs of continuous infusion
Nitroglycerin indications and dosages
Lower doses cause venodilation, higher cause arterodilation
Continuous infusions:
ADHF 5-10mcg/min, titrate by 5-10mcg/min q 3-5min up to 200mcg/min
Angina- (initial) 5-10mcg min, titrate by 5mcg/min q 5-10min up to 20mcg/min. If angina persists, increase by 10-20mcg/min q 3-5min up to 400mcg/min (200mcg/min soft max. per VPP)
Topical patch, transdermal: Initial: 0.2 to 0.4 mg/hour; increase dose as needed based on response and tolerability to a maximum of 0.8 mg/hour. Use a patch-on period of 12 to 14 hours/day and patch-off period (nitrate-free interval) of 10 to 12 hours/day to minimize the risk of tolerance.
Hypertensive crisis (adjunct, off label)
Variable efficacy compared to other agents (eg, inconsistent and transient BP response), possible reflex tachycardia, and possible reduced cardiac output. Goal of therapy is to reduce MAP by ~10% to 20% over the first hour, then by an additional 5% to 15% over the next 23 hours
Continuous IV infusion: Initial: 5 mcg/minute; increase based on BP response and tolerability in increments of 5 mcg/minute every 3 to 5 minutes up to 20 mcg/minute; if no response at a dose of 20 mcg/minute, may increase by 10 to 20 mcg/minute every 3 to 5 minutes to a maximum dose of 200 mcg/minute.
Nitroglycerin infusion prep
50mg/250mL (NS or D5W)= 200mcg/mL
Nitroglycerin Pharmacokinetics
Onset: IV immediate, SL 1-3min, transdermal ~30min
Duration: IV 3-5min, SL >25 min, transdermal 10-12hrs